“The Mitigating Role of Transresveratrol Against Doxorubicin-Induced Cardiotoxicity in Breast Cancer Patients via Modulating Mitochondrial Gene Expression: A Randomized Controlled Trial”. Journal of Carcinogenesis, vol. 23, no. 1, Oct. 2024, pp. 751-70, https://doi.org/10.64149/J.Carcinog.23.1.751-770.